The use of American ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind, placebo-controlled phase III study

eagle-i ID

Resource Type

Properties

1. ClinicalTrials.gov url

   http://www.clinicaltrials.gov/ct2/show/NCT00719563?term=N07C2&rank=1

2. Intervention

   American ginseng

3. Resource Description

   This randomized phase III trial is studying American ginseng to see how well it works in treating patients with fatigue caused by cancer.

4. Contact

   Berenberg, Jeffrey

5. PI

   Berenberg, Jeffrey

6. Topic

   cancer

7. Study Population

   Candidates are at least 18 years old and have been diagnosed with cancer within 2 years. The candidate must have finished at least one course of chemotherapy or targeted therapy or at least 1 week of radiation therapy and must have experienced fatigue for at least 1 month. There must be no brain metastasis or primary CNS cancer, there must have been no previous use of ginseng capsules.

8. Funded by

   North Central Cancer Treatment Group

9. Phase

   Phase 3 clinical trial

10. Performed by

    Clinical Protocol & Data Management Shared Resource